Trace amines depress GABAB response in dopaminergic neurons by inhibiting G-βγ-gated inwardly rectifying potassium channels

Molecular Pharmacology

Volumn 67, Issue 4, 2005, Pages 1283-1290

  Federici, Mauro ^b   Geracitano, Raffaella ^b   Tozzi, Alessandro ^b   Longone, Patrizia ^b   Di Angelantonio, Silvia ^b   Bengtson, C Peter ^b   Bernardi, Giorgio ^b   Mercuri, Nicola B ^a  

^a IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID B RECEPTOR; AMINE; BACLOFEN; INWARDLY RECTIFYING POTASSIUM CHANNEL; PHENETHYLAMINE; POTASSIUM; TRACE AMINE; TYRAMINE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; ATTENTION DEFICIT DISORDER; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; DRUG DEPENDENCE; G BETAGAMMA GATED INWARDLY RECTIFYING POTASSIUM CHANNEL; INHIBITORY POSTSYNAPTIC POTENTIAL; MALE; MESENCEPHALON; NEUROMODULATION; NEUROTRANSMITTER RELEASE; NONHUMAN; PARKINSON DISEASE; PATCH CLAMP; PRIORITY JOURNAL; RAT; SCHIZOPHRENIA; SYNAPTIC POTENTIAL; UPREGULATION;

ANIMALS; CALCIUM; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DEPRESSION, CHEMICAL; GTP-BINDING PROTEIN BETA SUBUNITS; GTP-BINDING PROTEIN GAMMA SUBUNITS; ION CHANNEL GATING; MALE; PHENETHYLAMINES; PHOSPHOLIPASE C; POTASSIUM CHANNELS, INWARDLY RECTIFYING; PROTEIN KINASE C; RATS; RATS, WISTAR; RECEPTORS, GABA-B; SUBSTANTIA NIGRA; SYNAPTIC TRANSMISSION; TYRAMINE; VENTRAL TEGMENTAL AREA;

EID: 15744390709     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.104.007427     Document Type: Article

References (40)

1. Berry MD (2004) Mammalian central nervous system trace amines. Pharmacologic amphetamines, physiologic neuromodulators. J Neurochem 90:257-271.
2. Bonci A and Williams JT (1996) A common mechanism mediates long-term changes in synaptic transmission after chronic cocaine and morphine. Neuron 16:631-639.
3. Borison RL, Havdala HS, and Diamond BI (1977) Chronic phenylethylamine stereotypy in rats: a new animal model for schizophrenia? Life Sci 21:117-122.
4. Borowsky B, Adham N, Jones KA, Raddatz R, Artymyshyn R, Ogozalek KL, Durkin MM, Lakhlani PP, Bonini JA, Pathirana S, et al. (2001) Trace amines: identification of a family of mammalian G protein-coupled receptors. Proc Natl Acad Sci USA 98:8966-8971.
5. Boulton AA (1976) Identification, distribution, metabolism and function of meta and para tyramine, phenylethylamine and tryptamine in brain. Adv Biochem Psychopharmacol 15:57-67.
6. Boulton AA (1982) Some aspects of basic psychopharmacology: the trace amines. Prog Neuropsychopharmacol Biol Psychiatry 6:563-570.
7. Bunzow JR, Sonders MS, Arttamangkul S, Harrison LM, Zhang G, Quigley DI, Darland T, Suchland KL, Pasumamula S, Kennedy JL, et al. (2001) Amphetamine, 3,4-methylenedioxymethamphetamine, lysergic acid diethylamide and metabolites of the catecholamine neurotransmitters are agonists of a rat trace amine receptor. Mol Pharmacol 60:1181-1188.
8. Cameron DL and Williams JT (1993) Dopamine D1 receptors facilitate transmitter release. Nature (Lond) 366:344-347.
9. B receptor-effector coupling. Nat Neurosci 5:415-424.
10. Durden DA and Philips SR (1980) Kinetic measurements of the turnover rates of phenylethylamine and tryptamine in vivo in the rat brain. J Neurochem 34:1725-1732.
11. B transmission onto dopaminergic neurones by an unconventional presynaptic action. J Physiol 540:119-128.
12. Geracitano R, Federici M, Frisco S, Bernardi G, and Mercuri NB (2004) Inhibitory effects of trace amines on rat midbrain dopaminergic neurons. Neuropharmacology 46:807-814.
13. B receptors is altered after repeated amphetamine treatment. Neuroscience 109:585-595.
14. Grace AA and Onn SP (1989) Morphology and electrophysiological properties of immunocytochemically identified rat dopamine neurons recorded in vitro. J Neurosci 9:3463-3481.
15. Hoang QV, Bajic D, Yanagisawa M, Nakajima S, and Nakajima Y (2003) Effects of orexin (hypocretin) on GIRK channels. J Neurophysiol 90:693-702.
16. + channels. FEBS Lett 405:291-298.
17. Janssen PA, Leysen JE, Megens AA, and Awouters FH (1999) Does phenylethylamine act as an endogenous amphetamine in some patients? Int J Neuropsychopharmacol 2:229-240.
18. Johnson SW, Mercuri NB, and North RA (1992) 5-hydroxytryptamine1B receptors block the GABAB synaptic potential in rat dopamine neurons. J Neurosci 12: 2000-2006.
19. Johnson SW and North RA (1992) Two types of neurone in the rat ventral tegmental area and their synaptic inputs. J Physiol 450:455-468.
20. Juorio AV, Paterson IA, Zhu MY, and Matte G (1991) Electrical stimulation of the substantia nigra and changes of 2-phenylethylamine synthesis in the rat striatum. J Neurochem 56:213-220.
21. Kandel E, Schwartz JH, and Jessel TM (2000) Principles of Neural Science, 4th ed, McGraw-Hill, New York.
22. Kunkel MT and Peralta EG (1995) Identification of domains conferring G protein regulation on inward rectifier potassium channels. Cell 83:443-449.
23. Lacey MG, Mercuri NB, and North RA (1988) On the potassium conductance increase activated by GABAB and dopamine D2 receptors in rat substantia nigra neurones. J Physiol 401:437-453.
24. Lewohl JM, Wilson WR, Mayfield RD, Brozowski SJ, Morrisett RA, and Harris RA (1999) G-protein-coupled inwardly rectifying potassium channels are targets of alcohol action. Nat Neurosci 2:1084-1090.
25. Liss B, Bruns R, and Roeper J (1999) Alternative sulfonylurea receptor expression defines metabolic sensitivity of K-ATP channels in dopaminergic midbrain neurons. EMBO (Eur Mol Biol Organ) J 18:833-846.
26. Mercuri NB, Bonci A, Calabresi P, Stefani A, and Bernardi G (1995) Properties of the hyperpolarization-activated cation current Ih in rat midbrain dopaminergic neurons. Eur J Neurosci 7:462-469.
27. + current in atrial myocytes. J Biol Chem 276:5650-5658.
28. Mundorf ML, Hochstetler SE, and Wightman RM (1999) Amine weak bases disrupt vesicular storage and promote exocytosis in chromaffin cells. J Neurochem 73: 2397-2405.
29. Nguyen TV and Juorio AV (1989) Binding sites for brain trace amines. Cell Mol Neurobiol 9:297-311.
30. Parker EM and Cubeddu LX (1988) Comparative effects of amphetamine, phenylethylamine and related drugs on dopamine efflux, dopamine uptake and mazindol binding. J Pharmacol Exp Ther 245:199-210.
31. 2+ ions. J Gen Physiol 114:673-684.
32. Sabelli HC, Borison RL, Diamond BI, Havdala HS, and Narasimhachari N (1978) Phenylethylamine and brain function. Biochem Pharmacol 27:1707-1711.
33. + ions depends on the presence of phosphatidylinositol phosphates. Proc Natl Acad Sci USA 85:1307-1312.
34. Tozzi A, Bengtson CP, Longone P, Carignani C, Fusco FR, Bernardi G, and Mercuri NB (2003) Involvement of transient receptor potential-like channels in responses to mGluR-I activation in midbrain dopamine neurons. Eur J Neurosci 18:2133-2145.
35. + channel in acutely dissociated rat substantia nigra neurones. Neuropharmacology 38:191-201.
36. Ungar F, Mosnaim AD, Ungar B, and Wolf ME (1977) Tyramine-binding by synaptosomes from rat brain: effect of centrally active drugs. Biol Psychiatry 12:661-668.
37. 3H]-tyramine in the central nervous system. Br J Pharmacol 89:15-25.
38. 3H]mazindol binding processes. Neurochem Res 14: 949-955.
39. White FJ (1996) Synaptic regulation of mesocorticolimbic dopamine neurons. Annu Rev Neurosci 19:405-436.
40. Wise RA and Bozarth MA (1987) A psychomotor stimulant theory of addiction. Psychol Rev 94:469-492.